Medicare Cost Sharing May Put Quadruple HF Therapy Out of Reach
Out-of-pocket (OOP) costs for Medicare enrollees receiving quadruple drug therapy for heart failure with reduced ejection fraction were "substantially higher ...
© 2022 Pharma News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy.